{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:21:39Z","timestamp":1779294099412,"version":"3.51.4"},"reference-count":82,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"\n OBJECTIVE<\/jats:title>\n Stereotactic gene therapy in children is challenging due to the fragility of the infant skull and long hours of infusion. The thalamus, an integrative hub for the entire cortex, has been shown to facilitate widespread gene\/protein delivery via axonal transport. The aim of this study was to evaluate the safety and accuracy of bilateral thalamic convection-enhanced delivery (CED) of adeno-associated virus (AAV) vectors for GM2 gangliosidoses in children and to assess outcomes based on post-infusion imaging.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n \n This clinical trial enrolled 10 pediatric patients, including 7 infants and toddlers and 3 children ranging in age from 5 to 12 years, who underwent bilateral thalamic rAAVrh8-HEXA\/HEXB delivery via CED for GM2 gangliosidoses. The approximate trajectory entered the middle frontal gyrus, lateral to the frontal horn and caudate, passing through the anterior limb of the internal capsule to the thalamus. Injection volumes ranged from 180 \u03bcL to 1250 \u03bcL at a rate of 4 \u03bcL\/min. The surgical technique for trajectory planning, cranial stabilization, operating room setup, stereotactic cannula placement, infusion parameters, and gene delivery was reviewed. The accuracy of catheter placement was calculated, and the volume of distribution (V\n d<\/jats:sub>\n ) versus the volume of infusate (V\n i<\/jats:sub>\n ) based on thalamic signal intensity on MRI was quantified.\n <\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n \n Ten children (age range 6 months to 12 years) with GM2 gangliosidosis were included. Twenty infusion cannulas were successfully placed for bilateral thalamic drug delivery. Intrathalamic cannula distance measurements ranged from 12.4 to 15.3 mm, and all the cannula steps were inside the thalamic boundaries to prevent backflow. There were no significant intraoperative complications. The mean targeting error was 1.3 \u00b1 0.8 mm. The calculated volume of thalamic coverage by the infusate signal ranged from 5.9% to 53.3% (mean 26.9% \u00b1 15.5%) in a dose escalating pattern. The V\n d<\/jats:sub>\n \/V\n i<\/jats:sub>\n ratio ranged from 0.60 to 2.8 (mean 2.0 \u00b1 0.6), depending on the infusate volume. The diffusate shape was circular to slightly ellipsoid in all patients.\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n \n In this study, the surgical technique used in the first in-human intrathalamic drug infusion gene therapy trial in young children with GM2 gangliosidosis was reviewed. The innovative stereotactic setup used robotic surgical assistance and ensured high-precision targeting and secure cannula placement during prolonged infusions, even in infants as young as 6 months of age. Post-infusion MRI confirmed that the infusate remained well contained within the thalamus. The mean V\n d<\/jats:sub>\n \/V\n i<\/jats:sub>\n ratio of 2.0 is consistent with the literature. Overall, bilateral thalamic delivery of AAV transgene in children was safe and well tolerated.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/2025.4.peds2569","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T01:55:43Z","timestamp":1755309343000},"page":"609-620","source":"Crossref","is-referenced-by-count":3,"title":["Robot-assisted intrathalamic infusion for gene therapy in young children: surgical considerations"],"prefix":"10.3171","volume":"36","author":[{"given":"Rrita","family":"Daci","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, UMass Chan Medical School;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Salman","family":"Shazeeb","sequence":"additional","affiliation":[{"name":"Department of Radiology, UMass Chan Medical School;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Owusu-Adjei","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, UMass Chan Medical School;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"K\u00fchn","sequence":"additional","affiliation":[{"name":"Department of Radiology, UMass Chan Medical School;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"King","sequence":"additional","affiliation":[{"name":"Department of Radiology, UMass Chan Medical School;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Parzych","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, UMass Chan Medical School; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spiro G.","family":"Spanakis","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, UMass Chan Medical School; and"},{"name":"Department of Pediatrics, UMass Chan Medical School, Worcester, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard P.","family":"Moser","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, UMass Chan Medical School;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence R.","family":"Flotte","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, UMass Chan Medical School; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oguz I.","family":"Cataltepe","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, UMass Chan Medical School;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"issue":"10","key":"b1","series-title":"Nat Rev Drug Discov","first-page":"767","article-title":"Gene therapy for neurological disorders: progress and prospects","volume":"17","author":"Deverman BE","year":"2018","unstructured":"Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY. Gene therapy for neurological disorders: progress and prospects. Nat Rev Drug Discov. 2018;17(10):767."},{"issue":"1","key":"b2","series-title":"Neurosurg Clin N Am","first-page":"101","article-title":"Direct convective delivery for nervous system gene therapy","volume":"36","author":"Elder JB","year":"2025","unstructured":"Elder JB, Lonser RR. Direct convective delivery for nervous system gene therapy. Neurosurg Clin N Am. 2025;36(1):101\u2013111."},{"issue":"2","key":"b3","series-title":"Nat Med","first-page":"251","article-title":"AAV gene therapy for Tay-Sachs disease","volume":"28","author":"Flotte TR","year":"2022","unstructured":"Flotte TR, Cataltepe O, Puri A, AAV gene therapy for Tay-Sachs disease. Nat Med. 2022;28(2):251\u2013259."},{"issue":"4","key":"b4","series-title":"Clin Pharmacol Ther","first-page":"743","article-title":"Gene therapy for rare neurological disorders","volume":"111","author":"Flotte TR","year":"2022","unstructured":"Flotte TR, Gessler DJ. Gene therapy for rare neurological disorders. Clin Pharmacol Ther. 2022;111(4):743\u2013757."},{"issue":"3","key":"b5","series-title":"Hum Gene Ther","first-page":"312","article-title":"Adeno-associated virus gene therapy in a sheep model of Tay-Sachs disease","volume":"29","author":"Gray-Edwards HL","year":"2018","unstructured":"Gray-Edwards HL, Randle AN, Maitland SA, Adeno-associated virus gene therapy in a sheep model of Tay-Sachs disease. Hum Gene Ther. 2018;29(3):312\u2013326."},{"issue":"2","key":"b6","series-title":"Neurosurg Clin N Am","first-page":"205","article-title":"Future applications: gene therapy","volume":"20","author":"Richardson RM","year":"2009","unstructured":"Richardson RM, Varenika V, Forsayeth JR, Bankiewicz KS. Future applications: gene therapy. Neurosurg Clin N Am. 2009;20(2):205\u2013210."},{"issue":"2","key":"b7","series-title":"Brain Pathol","first-page":"117","article-title":"Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations","volume":"24","author":"Barua NU","year":"2014","unstructured":"Barua NU, Gill SS, Love S. Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations. Brain Pathol. 2014;24(2):117\u2013127."},{"key":"b8","series-title":"World Neurosurg","first-page":"163","article-title":"Convection-enhanced delivery and principles of extracellular transport in the brain","volume":"151","author":"Faraji AH","year":"2021","unstructured":"Faraji AH, Rajendran S, Jaquins-Gerstl AS, Hayes HJ, Richardson RM. Convection-enhanced delivery and principles of extracellular transport in the brain. World Neurosurg. 2021;151:163\u2013171."},{"issue":"3","key":"b9","series-title":"J Neurosurg","first-page":"697","article-title":"Convection-enhanced delivery to the central nervous system","volume":"122","author":"Lonser RR","year":"2015","unstructured":"Lonser RR, Sarntinoranont M, Morrison PF, Oldfield EH. Convection-enhanced delivery to the central nervous system. J Neurosurg. 2015;122(3):697\u2013706."},{"issue":"7-8","key":"b10","series-title":"Hum Gene Ther","first-page":"349","article-title":"The challenge of gene therapy for neurological diseases: strategies and tools to achieve efficient delivery to the central nervous system","volume":"32","author":"Piguet F","year":"2021","unstructured":"Piguet F, de Saint Denis T, Audouard E, The challenge of gene therapy for neurological diseases: strategies and tools to achieve efficient delivery to the central nervous system. Hum Gene Ther. 2021;32(7-8):349\u2013374."},{"issue":"2","key":"b11","series-title":"Hum Gene Ther","first-page":"210","article-title":"Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum","volume":"23","author":"San Sebastian W","year":"2012","unstructured":"San Sebastian W, Richardson RM, Kells AP, Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum. Hum Gene Ther. 2012;23(2):210\u2013217."},{"issue":"10","key":"b12","series-title":"J Child Neurol","first-page":"1231","article-title":"Convection-enhanced delivery for the treatment of pediatric neurologic disorders","volume":"23","author":"Song DK","year":"2008","unstructured":"Song DK, Lonser RR. Convection-enhanced delivery for the treatment of pediatric neurologic disorders. J Child Neurol. 2008;23(10):1231\u20131237."},{"issue":"2","key":"b13","series-title":"J Neurosurg","first-page":"240","article-title":"Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics","volume":"113","author":"Yin D","year":"2010","unstructured":"Yin D, Richardson RM, Fiandaca MS, Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics. J Neurosurg. 2010;113(2):240\u2013248."},{"key":"b14","series-title":"Adv Tech Stand Neurosurg","first-page":"199","article-title":"Convection-enhanced delivery in children: techniques and applications","volume":"45","author":"Aquilina K","year":"2022","unstructured":"Aquilina K, Chakrapani A, Carr L, Kurian MA, Hargrave D. Convection-enhanced delivery in children: techniques and applications. Adv Tech Stand Neurosurg. 2022;45:199\u2013228."},{"issue":"22","key":"b15","series-title":"Hum Mol Genet","first-page":"4371","article-title":"Adeno-associated virus-mediated expression of \u03b2-hexosaminidase prevents neuronal loss in the Sandhoff mouse brain","volume":"20","author":"Sargeant TJ","year":"2011","unstructured":"Sargeant TJ, Wang S, Bradley J, Adeno-associated virus-mediated expression of \u03b2-hexosaminidase prevents neuronal loss in the Sandhoff mouse brain. Hum Mol Genet. 2011;20(22):4371\u20134380."},{"issue":"7","key":"b16","series-title":"Mol Ther","first-page":"1306","article-title":"Therapeutic response in feline Sandhoff disease despite immunity to intracranial gene therapy","volume":"21","author":"Bradbury AM","year":"2013","unstructured":"Bradbury AM, Cochran JN, McCurdy VJ, Therapeutic response in feline Sandhoff disease despite immunity to intracranial gene therapy. Mol Ther. 2013;21(7):1306\u20131315."},{"issue":"7","key":"b17","series-title":"Proc Natl Acad Sci U S A","first-page":"2407","article-title":"Efficient gene therapy-based method for the delivery of therapeutics to primate cortex","volume":"106","author":"Kells AP","year":"2009","unstructured":"Kells AP, Hadaczek P, Yin D, Efficient gene therapy-based method for the delivery of therapeutics to primate cortex. Proc Natl Acad Sci U S A. 2009;106(7):2407\u20132411."},{"issue":"17","key":"b18","series-title":"Int J Mol Sci","first-page":"6213","article-title":"GM2 gangliosidoses: clinical features, pathophysiological aspects, and current therapies","volume":"21","author":"Leal AF","year":"2020","unstructured":"Leal AF, Benincore-Florez E, Solano-Galarza D, GM2 gangliosidoses: clinical features, pathophysiological aspects, and current therapies. Int J Mol Sci. 2020;21(17):6213."},{"issue":"5","key":"b19","series-title":"Ann Neurol","first-page":"704","article-title":"Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson\u2019s disease","volume":"85","author":"Christine CW","year":"2019","unstructured":"Christine CW, Bankiewicz KS, Van Laar AD, Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson\u2019s disease. Ann Neurol. 2019;85(5):704\u2013714."},{"issue":"3","key":"b20","series-title":"Neurol Neurochir Pol","first-page":"220","article-title":"Advancing gene therapies, methods, and technologies for Parkinson\u2019s Disease and other neurological disorders","volume":"54","author":"Fiandaca MS","year":"2020","unstructured":"Fiandaca MS, Lonser RR, Elder JB, Zabek M, Bankiewicz KS. Advancing gene therapies, methods, and technologies for Parkinson\u2019s Disease and other neurological disorders. Neurol Neurochir Pol. 2020;54(3):220\u2013231."},{"issue":"6","key":"b21","series-title":"J Neurosurg","first-page":"1751","article-title":"Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders","volume":"134","author":"Lonser RR","year":"2021","unstructured":"Lonser RR, Akhter AS, Zabek M, Elder JB, Bankiewicz KS. Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders. J Neurosurg. 2021;134(6):1751\u20131763."},{"issue":"11","key":"b22","series-title":"J Neurol Neurosurg Psychiatry","first-page":"1210","article-title":"Data-driven evolution of neurosurgical gene therapy delivery in Parkinson\u2019s disease","volume":"91","author":"Richardson RM","year":"2020","unstructured":"Richardson RM, Bankiewicz KS, Christine CW, Data-driven evolution of neurosurgical gene therapy delivery in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2020;91(11):1210\u20131218."},{"issue":"8","key":"b23","series-title":"Lancet Oncol","first-page":"1040","article-title":"Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial","volume":"19","author":"Souweidane MM","year":"2018","unstructured":"Souweidane MM, Kramer K, Pandit-Taskar N, Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial. Lancet Oncol. 2018;19(8):1040\u20131050."},{"issue":"7","key":"b24","series-title":"Pharmaceutics","first-page":"660","article-title":"Convection enhanced delivery for diffuse intrinsic pontine glioma: review of a single institution experience","volume":"12","author":"Tosi U","year":"2020","unstructured":"Tosi U, Souweidane M. Convection enhanced delivery for diffuse intrinsic pontine glioma: review of a single institution experience. Pharmaceutics. 2020;12(7):660."},{"issue":"1","key":"b25","series-title":"Signal Transduct Target Ther","first-page":"78","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang JH","year":"2024","unstructured":"Wang JH, Gessler DJ, Zhan W, Gallagher TL, Gao G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther. 2024;9(1):78."},{"issue":"2","key":"b26","series-title":"J Neurosurg","first-page":"315","article-title":"Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time","volume":"90","author":"Chen MY","year":"1999","unstructured":"Chen MY, Lonser RR, Morrison PF, Governale LS, Oldfield EH. Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg. 1999;90(2):315\u2013320."},{"issue":"5","key":"b27","series-title":"Neurosurg Focus","first-page":"E7","article-title":"Robot-assisted procedures in pediatric neurosurgery","volume":"42","author":"De Benedictis A","year":"2017","unstructured":"De Benedictis A, Trezza A, Carai A, Robot-assisted procedures in pediatric neurosurgery. Neurosurg Focus. 2017;42(5):E7."},{"issue":"1 Suppl","key":"b28","series-title":"Neurosurgery","first-page":"ONS-E181","article-title":"A modification of the Mayfield horseshoe headrest allowing pin fixation and cranial immobilization in infants and young children","volume":"58","author":"Gupta N","year":"2006","unstructured":"Gupta N. A modification of the Mayfield horseshoe headrest allowing pin fixation and cranial immobilization in infants and young children. Neurosurgery. 2006;58(1 Suppl):ONS-E181."},{"issue":"6 Suppl","key":"b29","series-title":"J Neurosurg","first-page":"392","article-title":"Frameless, pinless stereotactic neurosurgery in children","volume":"104","author":"Reavey-Cantwell JF","year":"2006","unstructured":"Reavey-Cantwell JF, Bova FJ, Pincus DW. Frameless, pinless stereotactic neurosurgery in children. J Neurosurg. 2006;104(6 Suppl):392\u2013395."},{"issue":"5","key":"b30","series-title":"Neurosurgery","first-page":"678","article-title":"Complications of head immobilization devices in children: contact mechanics, and analysis of a single institutional experience","volume":"82","author":"Zaazoue MA","year":"2018","unstructured":"Zaazoue MA, Bedewy M, Goumnerova LC. Complications of head immobilization devices in children: contact mechanics, and analysis of a single institutional experience. Neurosurgery. 2018;82(5):678\u2013685."},{"key":"b31","series-title":"Clin Neurol Neurosurg","first-page":"42","article-title":"Frame-based stereotactic neurosurgery in children under the age of seven: Freiburg University\u2019s experience from 99 consecutive cases","volume":"130","author":"Furlanetti LL","year":"2015","unstructured":"Furlanetti LL, Monaco BA, Cordeiro JG, Lopez WO, Trippel M. Frame-based stereotactic neurosurgery in children under the age of seven: Freiburg University\u2019s experience from 99 consecutive cases. Clin Neurol Neurosurg. 2015;130:42\u201347."},{"issue":"6","key":"b32","series-title":"Expert Rev Neurother","first-page":"635","article-title":"Interventional MRI-guided catheter placement and real time drug delivery to the central nervous system","volume":"16","author":"Han SJ","year":"2016","unstructured":"Han SJ, Bankiewicz K, Butowski NA, Larson PS, Aghi MK. Interventional MRI-guided catheter placement and real time drug delivery to the central nervous system. Expert Rev Neurother. 2016;16(6):635\u2013639."},{"key":"b33","series-title":"J Control Release","first-page":"434","article-title":"AAV viral vector delivery to the brain by shape-conforming MR-guided infusions","volume":"240","author":"Bankiewicz KS","year":"2016","unstructured":"Bankiewicz KS, Sudhakar V, Samaranch L, San Sebastian W, Bringas J, Forsayeth J. AAV viral vector delivery to the brain by shape-conforming MR-guided infusions. J Control Release. 2016;240:434\u2013442."},{"key":"b34","series-title":"Methods Mol Biol","first-page":"217","article-title":"MRI-guided delivery of viral vectors","volume":"1382","author":"Salegio EA","year":"2016","unstructured":"Salegio EA, Bringas J, Bankiewicz KS. MRI-guided delivery of viral vectors. Methods Mol Biol. 2016;1382:217\u2013230."},{"issue":"21-22","key":"b35","series-title":"Hum Gene Ther","first-page":"886","article-title":"Neuroimaging applications for the delivery and monitoring of gene therapy for central nervous system diseases","volume":"35","author":"Daci R","year":"2024","unstructured":"Daci R, Gray-Edwards H, Shazeeb MS, Neuroimaging applications for the delivery and monitoring of gene therapy for central nervous system diseases. Hum Gene Ther. 2024;35(21-22):886\u2013895."},{"issue":"11-12","key":"b36","series-title":"Hum Gene Ther","first-page":"617","article-title":"Volume and infusion rate dynamics of intraparenchymal central nervous system infusion in a large animal model","volume":"31","author":"Taghian T","year":"2020","unstructured":"Taghian T, Horn E, Shazeeb MS, Volume and infusion rate dynamics of intraparenchymal central nervous system infusion in a large animal model. Hum Gene Ther. 2020;31(11-12):617\u2013625."},{"issue":"2","key":"b37","series-title":"Childs Nerv Syst","first-page":"263","article-title":"Robot-assisted stereoelectroencephalography in young children: technical challenges and considerations","volume":"38","author":"Boop S","year":"2022","unstructured":"Boop S, Barkley A, Emerson S, Robot-assisted stereoelectroencephalography in young children: technical challenges and considerations. Childs Nerv Syst. 2022;38(2):263\u2013267."},{"issue":"3","key":"b38","series-title":"J Neurosurg Pediatr","first-page":"297","article-title":"Accuracy of robot-assisted versus optical frameless navigated stereoelectroencephalography electrode placement in children","volume":"23","author":"Sharma JD","year":"2019","unstructured":"Sharma JD, Seunarine KK, Tahir MZ, Tisdall MM. Accuracy of robot-assisted versus optical frameless navigated stereoelectroencephalography electrode placement in children. J Neurosurg Pediatr. 2019;23(3):297\u2013302."},{"issue":"7","key":"b39","series-title":"Childs Nerv Syst","first-page":"2251","article-title":"Robot-assisted stereoelectroencephalography electrode placement in twenty-three pediatric patients: a high-resolution analysis of individual lead placement time and accuracy at a single institution","volume":"37","author":"Bonda DJ","year":"2021","unstructured":"Bonda DJ, Pruitt R, Theroux L, Robot-assisted stereoelectroencephalography electrode placement in twenty-three pediatric patients: a high-resolution analysis of individual lead placement time and accuracy at a single institution. Childs Nerv Syst. 2021;37(7):2251\u20132259."},{"issue":"5","key":"b40","series-title":"Neurol India","first-page":"503","article-title":"Accuracy and precision of targeting using frameless stereotactic system in deep brain stimulator implantation surgery","volume":"62","author":"Sharma M","year":"2014","unstructured":"Sharma M, Rhiew R, Deogaonkar M, Rezai A, Boulis N. Accuracy and precision of targeting using frameless stereotactic system in deep brain stimulator implantation surgery. Neurol India. 2014;62(5):503\u2013509."},{"issue":"1","key":"b41","series-title":"Nat Commun","first-page":"4251","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons","volume":"12","author":"Pearson TS","year":"2021","unstructured":"Pearson TS, Gupta N, San Sebastian W, Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. Nat Commun. 2021;12(1):4251."},{"issue":"10","key":"b1","series-title":"Nat Rev Drug Discov","first-page":"767","article-title":"Gene therapy for neurological disorders: progress and prospects","volume":"17","author":"Deverman BE","year":"2018","unstructured":"Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY. Gene therapy for neurological disorders: progress and prospects. Nat Rev Drug Discov. 2018;17(10):767."},{"issue":"1","key":"b2","series-title":"Neurosurg Clin N Am","first-page":"101","article-title":"Direct convective delivery for nervous system gene therapy","volume":"36","author":"Elder JB","year":"2025","unstructured":"Elder JB, Lonser RR. Direct convective delivery for nervous system gene therapy. Neurosurg Clin N Am. 2025;36(1):101\u2013111."},{"issue":"2","key":"b3","series-title":"Nat Med","first-page":"251","article-title":"AAV gene therapy for Tay-Sachs disease","volume":"28","author":"Flotte TR","year":"2022","unstructured":"Flotte TR, Cataltepe O, Puri A, AAV gene therapy for Tay-Sachs disease. Nat Med. 2022;28(2):251\u2013259."},{"issue":"4","key":"b4","series-title":"Clin Pharmacol Ther","first-page":"743","article-title":"Gene therapy for rare neurological disorders","volume":"111","author":"Flotte TR","year":"2022","unstructured":"Flotte TR, Gessler DJ. Gene therapy for rare neurological disorders. Clin Pharmacol Ther. 2022;111(4):743\u2013757."},{"issue":"3","key":"b5","series-title":"Hum Gene Ther","first-page":"312","article-title":"Adeno-associated virus gene therapy in a sheep model of Tay-Sachs disease","volume":"29","author":"Gray-Edwards HL","year":"2018","unstructured":"Gray-Edwards HL, Randle AN, Maitland SA, Adeno-associated virus gene therapy in a sheep model of Tay-Sachs disease. Hum Gene Ther. 2018;29(3):312\u2013326."},{"issue":"2","key":"b6","series-title":"Neurosurg Clin N Am","first-page":"205","article-title":"Future applications: gene therapy","volume":"20","author":"Richardson RM","year":"2009","unstructured":"Richardson RM, Varenika V, Forsayeth JR, Bankiewicz KS. Future applications: gene therapy. Neurosurg Clin N Am. 2009;20(2):205\u2013210."},{"issue":"2","key":"b7","series-title":"Brain Pathol","first-page":"117","article-title":"Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations","volume":"24","author":"Barua NU","year":"2014","unstructured":"Barua NU, Gill SS, Love S. Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations. Brain Pathol. 2014;24(2):117\u2013127."},{"key":"b8","series-title":"World Neurosurg","first-page":"163","article-title":"Convection-enhanced delivery and principles of extracellular transport in the brain","volume":"151","author":"Faraji AH","year":"2021","unstructured":"Faraji AH, Rajendran S, Jaquins-Gerstl AS, Hayes HJ, Richardson RM. Convection-enhanced delivery and principles of extracellular transport in the brain. World Neurosurg. 2021;151:163\u2013171."},{"issue":"3","key":"b9","series-title":"J Neurosurg","first-page":"697","article-title":"Convection-enhanced delivery to the central nervous system","volume":"122","author":"Lonser RR","year":"2015","unstructured":"Lonser RR, Sarntinoranont M, Morrison PF, Oldfield EH. Convection-enhanced delivery to the central nervous system. J Neurosurg. 2015;122(3):697\u2013706."},{"issue":"7-8","key":"b10","series-title":"Hum Gene Ther","first-page":"349","article-title":"The challenge of gene therapy for neurological diseases: strategies and tools to achieve efficient delivery to the central nervous system","volume":"32","author":"Piguet F","year":"2021","unstructured":"Piguet F, de Saint Denis T, Audouard E, The challenge of gene therapy for neurological diseases: strategies and tools to achieve efficient delivery to the central nervous system. Hum Gene Ther. 2021;32(7-8):349\u2013374."},{"issue":"2","key":"b11","series-title":"Hum Gene Ther","first-page":"210","article-title":"Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum","volume":"23","author":"San Sebastian W","year":"2012","unstructured":"San Sebastian W, Richardson RM, Kells AP, Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum. Hum Gene Ther. 2012;23(2):210\u2013217."},{"issue":"10","key":"b12","series-title":"J Child Neurol","first-page":"1231","article-title":"Convection-enhanced delivery for the treatment of pediatric neurologic disorders","volume":"23","author":"Song DK","year":"2008","unstructured":"Song DK, Lonser RR. Convection-enhanced delivery for the treatment of pediatric neurologic disorders. J Child Neurol. 2008;23(10):1231\u20131237."},{"issue":"2","key":"b13","series-title":"J Neurosurg","first-page":"240","article-title":"Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics","volume":"113","author":"Yin D","year":"2010","unstructured":"Yin D, Richardson RM, Fiandaca MS, Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics. J Neurosurg. 2010;113(2):240\u2013248."},{"key":"b14","series-title":"Adv Tech Stand Neurosurg","first-page":"199","article-title":"Convection-enhanced delivery in children: techniques and applications","volume":"45","author":"Aquilina K","year":"2022","unstructured":"Aquilina K, Chakrapani A, Carr L, Kurian MA, Hargrave D. Convection-enhanced delivery in children: techniques and applications. Adv Tech Stand Neurosurg. 2022;45:199\u2013228."},{"issue":"22","key":"b15","series-title":"Hum Mol Genet","first-page":"4371","article-title":"Adeno-associated virus-mediated expression of \u03b2-hexosaminidase prevents neuronal loss in the Sandhoff mouse brain","volume":"20","author":"Sargeant TJ","year":"2011","unstructured":"Sargeant TJ, Wang S, Bradley J, Adeno-associated virus-mediated expression of \u03b2-hexosaminidase prevents neuronal loss in the Sandhoff mouse brain. Hum Mol Genet. 2011;20(22):4371\u20134380."},{"issue":"7","key":"b16","series-title":"Mol Ther","first-page":"1306","article-title":"Therapeutic response in feline Sandhoff disease despite immunity to intracranial gene therapy","volume":"21","author":"Bradbury AM","year":"2013","unstructured":"Bradbury AM, Cochran JN, McCurdy VJ, Therapeutic response in feline Sandhoff disease despite immunity to intracranial gene therapy. Mol Ther. 2013;21(7):1306\u20131315."},{"issue":"7","key":"b17","series-title":"Proc Natl Acad Sci U S A","first-page":"2407","article-title":"Efficient gene therapy-based method for the delivery of therapeutics to primate cortex","volume":"106","author":"Kells AP","year":"2009","unstructured":"Kells AP, Hadaczek P, Yin D, Efficient gene therapy-based method for the delivery of therapeutics to primate cortex. Proc Natl Acad Sci U S A. 2009;106(7):2407\u20132411."},{"issue":"17","key":"b18","series-title":"Int J Mol Sci","first-page":"6213","article-title":"GM2 gangliosidoses: clinical features, pathophysiological aspects, and current therapies","volume":"21","author":"Leal AF","year":"2020","unstructured":"Leal AF, Benincore-Florez E, Solano-Galarza D, GM2 gangliosidoses: clinical features, pathophysiological aspects, and current therapies. Int J Mol Sci. 2020;21(17):6213."},{"issue":"5","key":"b19","series-title":"Ann Neurol","first-page":"704","article-title":"Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson\u2019s disease","volume":"85","author":"Christine CW","year":"2019","unstructured":"Christine CW, Bankiewicz KS, Van Laar AD, Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson\u2019s disease. Ann Neurol. 2019;85(5):704\u2013714."},{"issue":"3","key":"b20","series-title":"Neurol Neurochir Pol","first-page":"220","article-title":"Advancing gene therapies, methods, and technologies for Parkinson\u2019s Disease and other neurological disorders","volume":"54","author":"Fiandaca MS","year":"2020","unstructured":"Fiandaca MS, Lonser RR, Elder JB, Zabek M, Bankiewicz KS. Advancing gene therapies, methods, and technologies for Parkinson\u2019s Disease and other neurological disorders. Neurol Neurochir Pol. 2020;54(3):220\u2013231."},{"issue":"6","key":"b21","series-title":"J Neurosurg","first-page":"1751","article-title":"Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders","volume":"134","author":"Lonser RR","year":"2021","unstructured":"Lonser RR, Akhter AS, Zabek M, Elder JB, Bankiewicz KS. Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders. J Neurosurg. 2021;134(6):1751\u20131763."},{"issue":"11","key":"b22","series-title":"J Neurol Neurosurg Psychiatry","first-page":"1210","article-title":"Data-driven evolution of neurosurgical gene therapy delivery in Parkinson\u2019s disease","volume":"91","author":"Richardson RM","year":"2020","unstructured":"Richardson RM, Bankiewicz KS, Christine CW, Data-driven evolution of neurosurgical gene therapy delivery in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2020;91(11):1210\u20131218."},{"issue":"8","key":"b23","series-title":"Lancet Oncol","first-page":"1040","article-title":"Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial","volume":"19","author":"Souweidane MM","year":"2018","unstructured":"Souweidane MM, Kramer K, Pandit-Taskar N, Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial. Lancet Oncol. 2018;19(8):1040\u20131050."},{"issue":"7","key":"b24","series-title":"Pharmaceutics","first-page":"660","article-title":"Convection enhanced delivery for diffuse intrinsic pontine glioma: review of a single institution experience","volume":"12","author":"Tosi U","year":"2020","unstructured":"Tosi U, Souweidane M. Convection enhanced delivery for diffuse intrinsic pontine glioma: review of a single institution experience. Pharmaceutics. 2020;12(7):660."},{"issue":"1","key":"b25","series-title":"Signal Transduct Target Ther","first-page":"78","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang JH","year":"2024","unstructured":"Wang JH, Gessler DJ, Zhan W, Gallagher TL, Gao G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther. 2024;9(1):78."},{"issue":"2","key":"b26","series-title":"J Neurosurg","first-page":"315","article-title":"Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time","volume":"90","author":"Chen MY","year":"1999","unstructured":"Chen MY, Lonser RR, Morrison PF, Governale LS, Oldfield EH. Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg. 1999;90(2):315\u2013320."},{"issue":"5","key":"b27","series-title":"Neurosurg Focus","first-page":"E7","article-title":"Robot-assisted procedures in pediatric neurosurgery","volume":"42","author":"De Benedictis A","year":"2017","unstructured":"De Benedictis A, Trezza A, Carai A, Robot-assisted procedures in pediatric neurosurgery. Neurosurg Focus. 2017;42(5):E7."},{"issue":"1 Suppl","key":"b28","series-title":"Neurosurgery","first-page":"ONS-E181","article-title":"A modification of the Mayfield horseshoe headrest allowing pin fixation and cranial immobilization in infants and young children","volume":"58","author":"Gupta N","year":"2006","unstructured":"Gupta N. A modification of the Mayfield horseshoe headrest allowing pin fixation and cranial immobilization in infants and young children. Neurosurgery. 2006;58(1 Suppl):ONS-E181."},{"issue":"6 Suppl","key":"b29","series-title":"J Neurosurg","first-page":"392","article-title":"Frameless, pinless stereotactic neurosurgery in children","volume":"104","author":"Reavey-Cantwell JF","year":"2006","unstructured":"Reavey-Cantwell JF, Bova FJ, Pincus DW. Frameless, pinless stereotactic neurosurgery in children. J Neurosurg. 2006;104(6 Suppl):392\u2013395."},{"issue":"5","key":"b30","series-title":"Neurosurgery","first-page":"678","article-title":"Complications of head immobilization devices in children: contact mechanics, and analysis of a single institutional experience","volume":"82","author":"Zaazoue MA","year":"2018","unstructured":"Zaazoue MA, Bedewy M, Goumnerova LC. Complications of head immobilization devices in children: contact mechanics, and analysis of a single institutional experience. Neurosurgery. 2018;82(5):678\u2013685."},{"key":"b31","series-title":"Clin Neurol Neurosurg","first-page":"42","article-title":"Frame-based stereotactic neurosurgery in children under the age of seven: Freiburg University\u2019s experience from 99 consecutive cases","volume":"130","author":"Furlanetti LL","year":"2015","unstructured":"Furlanetti LL, Monaco BA, Cordeiro JG, Lopez WO, Trippel M. Frame-based stereotactic neurosurgery in children under the age of seven: Freiburg University\u2019s experience from 99 consecutive cases. Clin Neurol Neurosurg. 2015;130:42\u201347."},{"issue":"6","key":"b32","series-title":"Expert Rev Neurother","first-page":"635","article-title":"Interventional MRI-guided catheter placement and real time drug delivery to the central nervous system","volume":"16","author":"Han SJ","year":"2016","unstructured":"Han SJ, Bankiewicz K, Butowski NA, Larson PS, Aghi MK. Interventional MRI-guided catheter placement and real time drug delivery to the central nervous system. Expert Rev Neurother. 2016;16(6):635\u2013639."},{"key":"b33","series-title":"J Control Release","first-page":"434","article-title":"AAV viral vector delivery to the brain by shape-conforming MR-guided infusions","volume":"240","author":"Bankiewicz KS","year":"2016","unstructured":"Bankiewicz KS, Sudhakar V, Samaranch L, San Sebastian W, Bringas J, Forsayeth J. AAV viral vector delivery to the brain by shape-conforming MR-guided infusions. J Control Release. 2016;240:434\u2013442."},{"key":"b34","series-title":"Methods Mol Biol","first-page":"217","article-title":"MRI-guided delivery of viral vectors","volume":"1382","author":"Salegio EA","year":"2016","unstructured":"Salegio EA, Bringas J, Bankiewicz KS. MRI-guided delivery of viral vectors. Methods Mol Biol. 2016;1382:217\u2013230."},{"issue":"21-22","key":"b35","series-title":"Hum Gene Ther","first-page":"886","article-title":"Neuroimaging applications for the delivery and monitoring of gene therapy for central nervous system diseases","volume":"35","author":"Daci R","year":"2024","unstructured":"Daci R, Gray-Edwards H, Shazeeb MS, Neuroimaging applications for the delivery and monitoring of gene therapy for central nervous system diseases. Hum Gene Ther. 2024;35(21-22):886\u2013895."},{"issue":"11-12","key":"b36","series-title":"Hum Gene Ther","first-page":"617","article-title":"Volume and infusion rate dynamics of intraparenchymal central nervous system infusion in a large animal model","volume":"31","author":"Taghian T","year":"2020","unstructured":"Taghian T, Horn E, Shazeeb MS, Volume and infusion rate dynamics of intraparenchymal central nervous system infusion in a large animal model. Hum Gene Ther. 2020;31(11-12):617\u2013625."},{"issue":"2","key":"b37","series-title":"Childs Nerv Syst","first-page":"263","article-title":"Robot-assisted stereoelectroencephalography in young children: technical challenges and considerations","volume":"38","author":"Boop S","year":"2022","unstructured":"Boop S, Barkley A, Emerson S, Robot-assisted stereoelectroencephalography in young children: technical challenges and considerations. Childs Nerv Syst. 2022;38(2):263\u2013267."},{"issue":"3","key":"b38","series-title":"J Neurosurg Pediatr","first-page":"297","article-title":"Accuracy of robot-assisted versus optical frameless navigated stereoelectroencephalography electrode placement in children","volume":"23","author":"Sharma JD","year":"2019","unstructured":"Sharma JD, Seunarine KK, Tahir MZ, Tisdall MM. Accuracy of robot-assisted versus optical frameless navigated stereoelectroencephalography electrode placement in children. J Neurosurg Pediatr. 2019;23(3):297\u2013302."},{"issue":"7","key":"b39","series-title":"Childs Nerv Syst","first-page":"2251","article-title":"Robot-assisted stereoelectroencephalography electrode placement in twenty-three pediatric patients: a high-resolution analysis of individual lead placement time and accuracy at a single institution","volume":"37","author":"Bonda DJ","year":"2021","unstructured":"Bonda DJ, Pruitt R, Theroux L, Robot-assisted stereoelectroencephalography electrode placement in twenty-three pediatric patients: a high-resolution analysis of individual lead placement time and accuracy at a single institution. Childs Nerv Syst. 2021;37(7):2251\u20132259."},{"issue":"5","key":"b40","series-title":"Neurol India","first-page":"503","article-title":"Accuracy and precision of targeting using frameless stereotactic system in deep brain stimulator implantation surgery","volume":"62","author":"Sharma M","year":"2014","unstructured":"Sharma M, Rhiew R, Deogaonkar M, Rezai A, Boulis N. Accuracy and precision of targeting using frameless stereotactic system in deep brain stimulator implantation surgery. Neurol India. 2014;62(5):503\u2013509."},{"issue":"1","key":"b41","series-title":"Nat Commun","first-page":"4251","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons","volume":"12","author":"Pearson TS","year":"2021","unstructured":"Pearson TS, Gupta N, San Sebastian W, Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. Nat Commun. 2021;12(1):4251."}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/36\/5\/article-p609.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/36\/5\/article-p609.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/36\/5\/article-p609.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:46:55Z","timestamp":1772804815000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/36\/5\/article-p609.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":82,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/2025.4.peds2569","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,1]]}}}